The report titled “United States In-Vitro Diagnostics Market Analysis 2024-2030: Industry Trends, Growth, Share, Outlook, and Opportunity Company Analysis” has been included in ResearchAndMarkets.com’s offerings. The United States In-Vitro Diagnostics (IVD) Market is projected to reach approximately US$ 56.52 Billion…
GE HealthCare (Nasdaq: GEHC) is set to exhibit its cutting-edge technologies in image guiding solutions, surgery, ultrasound, and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting from March 23-28 in Salt Lake City, UT. The…
The “Global Balloon Catheter Market Forecast 2024-2030: Industry Trends, Growth, Share, Company Analysis” now available on ResearchAndMarkets.com The Global Balloon Catheter Market is Projected to Reach Nearly US$ 7 Billion by 2030 The global market for balloon catheters is expected…
Baron & Budd, P.C., a national law firm, is delighted to share that shareholder Holly Werkema has been selected for the 2024 Compassionate Counsel Award. This prestigious honor is bestowed each year by The Milestone Charitable Foundation on a distinguished…
The report titled “Global Skull Clamp Market: Product, Application, Material, Accessories, End User, Regional Analysis, COVID-19 Impact, and Forecast 2029” is now available on ResearchAndMarkets.com. The global market for skull clamps reached a value of US$2.21 billion in 2023 and…
SEQSTER PDM Inc. (SEQSTER), a leading patient-centric healthcare technology company, has been chosen by the Multiple Sclerosis Association of America (MSAA) for its patient-centricity, 1-Click Records™, and advanced longitudinal health record. SEQSTER brings together individuals living with multiple sclerosis (MS),…
Dr. Gary K. Michelson and Alya Michelson were honored with the 2024 Humanitarian Award at the World Brain Mapping Foundation’s 21st Gathering for Cure (GFC) Awards Gala held at the Biltmore Hotel in Los Angeles. The prestigious award recognizes individuals…
At the USCAP annual conference in Baltimore, MD, from March 25-28, 2024, Pramana, Inc. will exhibit its advanced solutions for Digital Pathology 2.0 at booth #549. Pramana will showcase its vast experience and cutting-edge technologies, such as the development of…
Castle Biosciences, Inc. (Nasdaq: CSTL), a company focused on improving patient care through innovative tests, has announced the presentation of new data showcasing the performance of its DecisionDx-Melanoma test in predicting the risk of sentinel lymph node (SLN) positivity in…
Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. have made a joint announcement regarding the recent developments related to bempedoic acid (marketed as NILEMDO®) and the bempedoic acid/ezetimibe fixed combination tablet (marketed as NUSTENDI®) in the European market. The Committee…
Esperion (NASDAQ: ESPR) announced today that the FDA has approved expanded labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets. This approval is based on positive CLEAR Outcomes data and includes indications for cardiovascular risk reduction…
Meridian Health Plan of Illinois, Inc. (Meridian), a company that provides managed care services under government sponsorship to various segments of the population such as families, children, seniors, and individuals with complex medical needs, announced today that it will offer…